Skip to content Skip to footer

International Cannabis Weekly: 374

November 8, 2024

Highlights

Share this story
Highlights

WHAT DOES TRUMP’S AMERICA MEAN FOR CANNABIS?

As the most consequential US election in recent history comes to close after a long and turbulent campaign, the dust is beginning to settle on the prospective outlook for cannabis under the new administration.

READ MORE  »

GERMANY ANNOUNCES FURTHER PLANNED ADULT-USE TRIALS

READ MORE »

FLORIDA & NORTH DAKOTA VOTE AGAINST CANNABIS LEGALISATION

READ MORE »

Highlights

Share this story
Europe

Highlights

Share this story
Upcoming Event

Highlights

Share this story
United States
  • U.S. cannabis markets on the ballot this year could generate US$3 billion in revenue in first year.
  • Voters in Texas cities approve local initiatives decriminalising low-level cannabis possession.
  • Nebraska voters approve medical cannabis legalisation after years of advocacy despite legal obstacles.
  • Oregon passes ballot measure to protect cannabis industry workers’ union rights in the state.
  • Medical cannabis legalisation passes in every Kentucky city and county voting on the measure.
  • Ohio’s adult-use cannabis market reaches US$143 million in sales within launch period’s first weeks.

Highlights

Share this story
Canada

Highlights

Share this story
LATAM & The Caribbean

Highlights

Share this story
APAC

Highlights

Share this story
Africa & The Middle East
  • Cannapharma Rx set to complete additional shipments in Africa to expand its regional market.
  • IM Cannabis announces plans to release third-quarter financial report next week in November.
Latest Issues

Insights

on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.

Market Briefing Request

Please complete your details and a representative will be in contact

In Depth Analysis Session Request

Please complete your details and a representative will be in contact

Data Access Request

Please complete your details and a representative will be in contact